In this article we will dive into HIMS & HERS HEALTH INC (NYSE:HIMS) as a possible candidate for growth investing. Investors should always do their own research, but we noticed HIMS & HERS HEALTH INC showing up in our Louis Navellier growth screen, which makes it worth to investigate a bit more.
Key Considerations for Growth Investors.
In terms of Return on Equity(ROE), HIMS & HERS HEALTH INC is performing well, achieving a 23.01% ratio. This highlights the company's effective allocation of shareholder investments and signifies its commitment to maximizing returns.
With a track record of beating EPS estimates in the last 4 quarters, HIMS & HERS HEALTH INC showcases its consistent ability to deliver earnings surprises. This reflects the company's strong execution and its competitive position in the market.
HIMS & HERS HEALTH INC has achieved significant 1-year revenue growth of 56.7%, signaling its ability to capture market opportunities and drive top-line expansion. This growth indicates the company's effective execution and its potential for continued success.
The recent q2q revenue growth of 77.13% of HIMS & HERS HEALTH INC showcases the company's ability to generate increasing revenue in a short period, reflecting its positive growth trajectory.
HIMS & HERS HEALTH INC has experienced notable growth in its operating margin over the past year, reflecting improved operational performance. This growth suggests the company's ability to generate higher profits from its core business activities.
The free cash flow (FCF) of HIMS & HERS HEALTH INC has seen steady growth over the past year, indicating enhanced cash flow generation and financial health. This trend underscores the company's effective capital management and its ability to generate sustainable cash flows.
HIMS & HERS HEALTH INC has shown positive momentum in its earnings per share (EPS) on a quarter-to-quarter (Q2Q) basis, with a 250.0% increase. This reflects the company's successful execution of its business strategies and its commitment to delivering improved financial results.
Over the past 3 months, analysts have adjusted their EPS Estimate for HIMS & HERS HEALTH INC with a 15.37% change. This highlights the evolving outlook on the company's EPS potential.
The recent financial report of HIMS & HERS HEALTH INC demonstrates a 250.0% increase in quarterly earnings compared to the previous quarter. This growth indicates positive momentum in the company's financials and suggests a promising upward trend
accelerating EPS growth for HIMS & HERS HEALTH INC: the current Q2Q growth of 250.0% exceeds the previous year Q2Q growth of 55.56%.
A complete fundamental analysis of NYSE:HIMS
Every day, ChartMill assigns a Fundamental Rating to each stock, providing a score ranging from 0 to 10. This rating is determined by evaluating various fundamental indicators and properties.
HIMS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 113 industry peers in the Health Care Providers & Services industry. HIMS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. HIMS has a decent growth rate and is not valued too expensively.
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.